Related Experiment Video
Updated: May 25, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer
1Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University School of Medicine, Xi'an 710061, the People's Republic of China.
Background:
The phosphoinositide 3-kinase (PI3K)/Akt pathway plays a fundamental role in cell proliferation and survival in human tumorigenesis, including gastric cancer. PIK3CA mutations and amplification are two major causes of overactivation of this pathway in human cancers. However, until this work, there was no sound investigation on the association of PIK3CA mutations and amplification with clinical outcome in gastric cancer, particularly the latter.
Methods:
Using direct sequencing and real-time quantitative PCR, we examined PIK3CA mutations and amplification, and their association with clinicopathological characteristics and clinical outcome of gastric cancer patients.
Results:
PIK3CA mutations and amplification were found in 8/113 (7.1%) and 88/131 (67%) gastric cancer patients, respectively. PIK3CA amplification was closely associated with increased phosphorylated Akt (p-Akt) level. No relationship was found between PIK3CA mutations and clinicopathological characteristics and clinical outcome in gastric cancer. PIK3CA amplification was significantly positively associated with cancer-related death. Importantly, Kaplan-Meier survival curves revealed that the patients with PIK3CA amplification had significantly shorter survival times than the patients without PIK3CA amplification.
Conclusions:
Our data showed that PIK3CA mutations were not common, but its amplification was very common in gastric cancer and may be a major mechanism in activating the PI3K/Akt pathway in gastric cancer. Importantly, Kaplan-Meier survival curves revealed that PIK3CA amplification was significantly positively associated with poor survival of gastric cancer patients. Collectively, the PI3K/Akt signaling pathway may be an effective therapeutic target in gastric cancer.
Insights
PIK3CA amplification is common in gastric cancer, unlike mutations, and is linked to poorer patient survival. This suggests the PI3K/Akt pathway is a potential therapeutic target for gastric cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The phosphoinositide 3-kinase (PI3K)/Akt pathway is crucial for cell growth and survival in cancers, including gastric cancer.
- PIK3CA mutations and amplification frequently activate this pathway in various human cancers.
- Previous research lacked comprehensive analysis of PIK3CA alterations and their impact on gastric cancer patient outcomes.
Purpose of the Study:
- To investigate the prevalence of PIK3CA mutations and amplification in gastric cancer.
- To determine the association between PIK3CA alterations and clinicopathological features.
- To evaluate the prognostic significance of PIK3CA amplification in gastric cancer patients.
Main Methods:
- Direct sequencing was used to detect PIK3CA mutations.
- Real-time quantitative PCR assessed PIK3CA amplification.
- Kaplan-Meier survival analysis correlated PIK3CA status with patient outcomes.
Main Results:
- PIK3CA mutations occurred in 7.1% of patients, while amplification was found in 67%.
- PIK3CA amplification correlated with increased phosphorylated Akt (p-Akt) levels and cancer-related death.
- Patients with PIK3CA amplification exhibited significantly shorter survival times.
Conclusions:
- PIK3CA amplification is a frequent event in gastric cancer, unlike mutations, and is a key driver of PI3K/Akt pathway activation.
- PIK3CA amplification serves as a significant negative prognostic marker for gastric cancer patients.
- Targeting the PI3K/Akt signaling pathway presents a promising therapeutic strategy for gastric cancer.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
Gastritis II: Pathophysiology
